HomeCompareMJIN vs JNJ

MJIN vs JNJ: Dividend Comparison 2026

MJIN yields 13.04% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MJIN wins by $27.2K in total portfolio value
10 years
MJIN
MJIN
● Live price
13.04%
Share price
$15.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.2K
Annual income
$2,934.56
Full MJIN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MJIN vs JNJ

📍 MJIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMJINJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MJIN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MJIN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MJIN
Annual income on $10K today (after 15% tax)
$1,108.58/yr
After 10yr DRIP, annual income (after tax)
$2,494.38/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MJIN beats the other by $1,790.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MJIN + JNJ for your $10,000?

MJIN: 50%JNJ: 50%
100% JNJ50/50100% MJIN
Portfolio after 10yr
$33.6K
Annual income
$1,881.17/yr
Blended yield
5.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MJIN
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MJIN buys
0
JNJ buys
0
No recent congressional trades found for MJIN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMJINJNJ
Forward yield13.04%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$47.2K$20.0K
Annual income after 10y$2,934.56$827.78
Total dividends collected$20.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MJIN vs JNJ ($10,000, DRIP)

YearMJIN PortfolioMJIN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,004$1,304.21$10,676$355.77+$1.3KMJIN
2$14,308$1,463.18$11,407$389.39+$2.9KMJIN
3$16,939$1,629.86$12,198$426.53+$4.7KMJIN
4$19,928$1,803.38$13,056$467.62+$6.9KMJIN
5$23,306$1,982.82$13,987$513.12+$9.3KMJIN
6$27,105$2,167.20$14,998$563.56+$12.1KMJIN
7$31,357$2,355.54$16,098$619.52+$15.3KMJIN
8$36,099$2,546.85$17,295$681.69+$18.8KMJIN
9$41,366$2,740.17$18,599$750.82+$22.8KMJIN
10$47,197$2,934.56$20,022$827.78+$27.2KMJIN

MJIN vs JNJ: Complete Analysis 2026

MJINStock

The fund invests in financial instruments that, in combination, provide daily inverse exposure to the index or to ETFs that track the index to seek returns equal to -200% of the daily return of the index. The index tracks the performance of the common stock of companies across the globe. The fund will only directly invest in companies that are engaged exclusively in legal activities under applicable national and local laws, including U.S. federal and state laws. It is non-diversified.

Full MJIN Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MJIN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MJIN vs SCHDMJIN vs JEPIMJIN vs OMJIN vs KOMJIN vs MAINMJIN vs ABBVMJIN vs MRKMJIN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.